Designation Committee for Postdoctoral Education and Training Programs in Psychopharmacology for Prescriptive Authority

As a response to advances that have occurred in psychopharmacology education and training and prescriptive authority legislation in recent years, the APA has established a process to designate postdoctoral education and training programs in psychopharmacology.

This committee is composed of six members and is responsible for oversight and implementation of the designation system for psychopharmacology education and training programs. The purpose of designation is to afford public recognition of education and training programs that meet certain minimum standards and published criteria, which are set forth in Designation Criteria for Postdoctoral Education and Training Programs in Psychopharmacology for Prescriptive Authority (PDF, 62KB), approved by the APA Council of Representatives in August 2009. 

The process of designation is voluntary, to be initiated by the program seeking designation and shall be governed by policies and procedures(PDF, 32KB).

Interested programs may submit applications, which will be considered by the RxP Designation Committee at its fall 2014 meeting. Applications must be received by the May 2, 2014 deadline.

Applications must be submitted electronically; a single PDF file that is searchable and has bookmarks is preferred.

For more information, please contact Catherine Grus, PhD, or Deborah Baker, JD.

Staff Liaisons

Members

  • 2014 Chair: Joseph E. Comaty, PhD, MP (2012-14)

  • Marlin C. Hoover, PhD, MS, ABPP-CL (2013-15)

  • Neal R. Morris, EdD, MS (2014-16)

  • Linda O. Summers, PhD, MPH, MSN, MA (2012-14)

  • Steven R. Tulkin, PhD (2014-16)

  • Alice M. Young, PhD (2013-15)

Call for Nominations

APA's Board of Education Affairs (BEA) and the Committee for the Advancement of Professional Practice (CAPP) are seeking nominations to fill two seats on the RxP Designation Committee. One of the open seats is for a member of the public. Each appointment will serve a three-year term beginning Jan. 1, 2015. Committee members shall meet in-person once a year in the fall at APA headquarters and may work, as needed, throughout the year via email and conference calls.

The RxP Designation Committee welcomes nominations of individuals who have expertise in any of the following domains:

  • Psychopharmacology postdoctoral program directors.
  • Basic psychopharmacology science or clinical psychopharmacology research.
  • Prescriptive authority in psychology.
  • Prescriptive authority in another health care profession.
  • Health care system quality assurance.

Other areas of interest are developmental psychopharmacology and ethnic/cultural factors that can influence psychopharmacological decision-making. One committee member slot is designated for a public member; while the remaining five member slots are comprised of psychologists who are APA members. Appointments to the committee are made jointly by BEA and CAPP, and confirmed by the APA Board of Directors. Those appointed to the committee will be notified in writing.

Candidates are asked to submit the following:

  • Letter indicating his or her willingness to serve if selected.
  • 75-word description of qualifications as relates to the areas of expertise noted above.
  • Current curriculum vita.

The deadline for all nominations is Sept. 1, 2014. If you are interested in serving on the committee, or know of someone else who would be qualified for this position, please send nominations, along with the above-described information, to Jan-Sheri Morris. Please note that nominators of other individuals are responsible for ensuring that these materials are submitted.

Policies, Procedures and Other Resources

Annual Reports